Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.13 USD | +1.51% | -8.22% | -14.82% |
Business Summary
Number of employees: 3,401
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Therapies
100.0
%
| 2,096 | 100.0 % | 2,419 | 100.0 % | +15.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
31.9
%
| 684 | 32.6 % | 771 | 31.9 % | +12.72% |
Europe
27.7
%
| 651 | 31.1 % | 669 | 27.7 % | +2.82% |
Rest of World
19.4
%
| 312 | 14.9 % | 468 | 19.4 % | +50.28% |
Latin America
13.7
%
| 267 | 12.7 % | 332 | 13.7 % | +24.60% |
Global
7.4
%
| 182 | 8.7 % | 178 | 7.4 % | -2.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 56 | 01/12 |
Brian Mueller
DFI | Director of Finance/CFO | 50 | 01/02/01 |
Kevin Eggan
CTO | Chief Tech/Sci/R&D Officer | - | 05/20/05 |
Philip Lo Scalzo
CMP | Compliance Officer | - | 01/07/01 |
Chief Tech/Sci/R&D Officer | - | 01/08/01 | |
C. Guyer
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Stuart Bunting
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/01 |
Henry Fuchs
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/09/01 |
Director/Board Member | 70 | 16/05/16 | |
Traci McCarty
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 04/16/04 |
Director/Board Member | 70 | 16/05/16 | |
Randy Meier
CHM | Chairman | 65 | 14/06/14 |
Elaine Heron
BRD | Director/Board Member | 76 | 01/02/01 |
V. Lawlis
BRD | Director/Board Member | 72 | 01/07/01 |
May Kin Ho
BRD | Director/Board Member | 71 | 17/21/17 |
Mark Enyedy
BRD | Director/Board Member | 60 | 27/12 |
Robert Hombach
BRD | Director/Board Member | 58 | 29/17/29 |
Willard Dere
BRD | Director/Board Member | 70 | 18/16/18 |
Director/Board Member | 66 | 10/19/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 189,776,577 | 188,179,486 ( 99.16 %) | 0 | 99.16 % |
Company contact information
BioMarin Pharmaceutical, Inc.
770 Lindaro Street
94901, San Rafael
+415 506 6700
http://www.biomarin.comGroup companies
Name | Category and Sector |
---|---|
BioMarin International Ltd.
BioMarin International Ltd. BiotechnologyHealth Technology BioMarin International develops and commercializes biopharmaceuticals. The company was founded on June 16, 2011 and is headquartered in Dublin, Ireland. |
Biotechnology
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.82% | 15.36B | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B | |
+0.95% | 7.72B |
- Stock Market
- Equities
- BMRN Stock
- Company BioMarin Pharmaceutical Inc.